A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer (NCT07169851)
A Phase 2, Double-blind, Placebo-Controlled Study to Evaluate LY3537021 for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Adult Participants With Malignant Disease
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to check how well LY35327021 works and how safe it is for controlling nausea and vomiting caused by chemotherapy. Participants who join this study will be in it until all parts are finished, which could take about 2 months.
Who can join: Review the eligibility criteria below.
Location: Marin Cancer Care — Greenbrae, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (68 Sites)
Showing the first 25 of 68 sites.
- Marin Cancer Care — Greenbrae, California
- City of Hope Orange County Lennar Foundation Cancer Center — Irvine, California
- Cancer and Blood Specialty Clinic — Los Alamitos, California
- BASS Cancer Center — Walnut Creek, California
- UCHealth Harmony — Fort Collins, Colorado
- Clavis Medical — Miami Lakes, Florida
- BRCR Global - Tamarac — Tamarac, Florida
- Summit Cancer Care, PC — Savannah, Georgia
- Hope and Healing Cancer Services — Hinsdale, Illinois
- Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana
- North Mississippi Hematology and Oncology Associates — Tupelo, Mississippi
- Laura and Isaac Perlmutter Cancer Center — New York, New York
- New York Cancer and Blood Specialists — Shirley, New York
- Oncology Specialists of Charlotte — Charlotte, North Carolina
- Southern Oncology Specialists — Huntersville, North Carolina
- Asante Rogue Regional Medical Center — Medford, Oregon
- World Research Link — Baytown, Texas
- John Peter Smith Hospital — Fort Worth, Texas
- Kelsey-Seybold Clinic — Houston, Texas
- Community Cancer Trials of Utah — Ogden, Utah
- Cancer Care Northwest — Spokane, Washington
- Ballarat Health Services — Ballarat Central,
- Bendigo Health Care Group — Bendigo,
- WA Country Health Service Trial Centre — Perth,
- Goulburn Valley Health — Shepparton,
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Nausea
- Acupressure Wristbands for GLP-1RA Related Nausea — Jupiter, Florida
- Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE) — Scottsdale, Arizona
Explore by condition: All Nausea clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.